Pacira BioSciences, Inc. (PCRX) Ownership
PCRX ownership summary
as of October 18, 2026- Institutions
- 105.9% of shares outstanding
- Insiders
- 1.34% of shares outstanding
- Shares outstanding
- 39.9M
- Float
- 39.1M shares available to trade
- Short interest
- 29.12% 8.1M shares short
- Days to cover
- 14.52 short interest up 6.8% vs prior month
- Institutions 105.87%
- Insiders 1.34%
PCRX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 16.82% | 6.7M | $243.7M | −29,534 (−0.4%) | June 30, 2026 |
| 2 | Doma Perpetual Capital Management LLC | 6.97% | 2.8M | $100.9M | — | June 30, 2026 |
| 3 | Vanguard Portfolio Management, LLC | 6.04% | 2.4M | $87.4M | −95,048 (−3.8%) | June 30, 2026 |
| 4 | Dimensional Fund Advisors, Inc. | 5.28% | 2.1M | $76.4M | +42,648 (+2.1%) | June 30, 2026 |
| 5 | State Street Corp | 5.17% | 2.1M | $74.9M | +140,367 (+7.3%) | June 30, 2026 |
| 6 | D. E. Shaw & Co LP | 4.89% | 2.0M | $70.9M | −32,392 (−1.6%) | June 30, 2026 |
| 7 | Renaissance Technologies Corp | 4.35% | 1.7M | $63.0M | −91,700 (−5.0%) | June 30, 2026 |
| 8 | Vanguard Capital Management, LLC | 4.24% | 1.7M | $61.5M | −92,478 (−5.2%) | June 30, 2026 |
| 9 | The Goldman Sachs Group Inc | 3.83% | 1.5M | $55.5M | −42,787 (−2.7%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 2.91% | 1.2M | $42.1M | +14,873 (+1.3%) | June 30, 2026 |
| 11 | Morgan Stanley - Brokerage Accounts | 2.87% | 1.1M | $41.6M | −247,894 (−17.8%) | June 30, 2026 |
| 12 | American Century Companies Inc | 2.55% | 1.0M | $37.0M | +180,530 (+21.6%) | June 30, 2026 |
| 13 | UBS Group AG | 2.31% | 920K | $33.4M | +358,177 (+63.7%) | June 30, 2026 |
| 14 | Impax Asset Management Group PLC | 1.88% | 750K | $27.3M | — | June 30, 2026 |
| 15 | Two Sigma Investments LLC | 1.82% | 725K | $26.3M | +197,753 (+37.5%) | June 30, 2026 |
| 16 | Charles Schwab Investment Management Inc | 1.73% | 691K | $25.1M | −41,256 (−5.6%) | June 30, 2026 |
| 17 | Gagnon Securities LLC | 1.53% | 609K | $22.1M | −8,893 (−1.4%) | June 30, 2026 |
| 18 | LSV Asset Management | 1.53% | 608K | $22.1M | +91,276 (+17.7%) | June 30, 2026 |
| 19 | Wellington Management Company LLP | 1.41% | 563K | $20.5M | +85,075 (+17.8%) | June 30, 2026 |
| 20 | Northern Trust Corp | 1.32% | 527K | $19.1M | +7,370 (+1.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 1.1M shares and 9 cut 682K.
PCRX top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Small-Cap ETF | 5.95% | 2.4M | $86.2M | +612 (+0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.01% | 1.2M | $43.6M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.57% | 1.0M | $37.2M | −11,776 (−1.1%) | September 30, 2026 |
| 4 | Avantis US Small Cap Value ETF | 2.25% | 898K | $32.6M | +7,344 (+0.8%) | September 30, 2026 |
| 5 | Vanguard Small Cap Index | 2.03% | 808K | $29.4M | −50,353 (−5.9%) | September 30, 2026 |
| 6 | Impax Small Cap Institutional | 1.88% | 750K | $27.3M | — | August 31, 2026 |
| 7 | DFA US Small Cap Value I | 1.43% | 570K | $20.7M | — | August 31, 2026 |
| 8 | Vanguard MStar Small Cap Value Index | 1.32% | 525K | $19.1M | −20,784 (−3.8%) | September 30, 2026 |
| 9 | Fidelity Small Cap Index | 1.08% | 433K | $15.7M | +2,782 (+0.6%) | July 31, 2026 |
| 10 | iShares S&P Small-Cap 600 Growth ETF | 0.93% | 369K | $13.4M | — | September 30, 2026 |
| 11 | State Street SPDR Port S&P 600 Sm CpETF | 0.91% | 364K | $13.2M | — | September 30, 2026 |
| 12 | State Street® SPDR® S&P® PhrmctlsETF | 0.91% | 363K | $13.2M | −4,510 (−1.2%) | September 30, 2026 |
| 13 | Fidelity Enhanced Small Cap Core ETF | 0.87% | 347K | $12.6M | +726 (+0.2%) | September 30, 2026 |
| 14 | iShares Russell 2000 Value ETF | 0.86% | 342K | $12.4M | +518 (+0.2%) | September 30, 2026 |
| 15 | Applied Finance Explorer Institutional | 0.69% | 274K | $9.9M | +3,610 (+1.3%) | July 31, 2026 |
| 16 | AZ Fd1 AZ Equity Best Value A - EUR Acc | 0.65% | 259K | $9.4M | −5,113 (−1.9%) | August 31, 2026 |
| 17 | Vanguard Tax-Managed Small Cap Adm | 0.64% | 254K | $9.2M | — | September 30, 2026 |
| 18 | DWS Small Cap Core S | 0.63% | 250K | $9.1M | −99,906 (−28.6%) | August 31, 2026 |
| 19 | Dimensional US Small Cap Value ETF | 0.59% | 235K | $8.5M | — | September 24, 2026 |
| 20 | Vanguard Russell 2000 ETF | 0.58% | 231K | $8.4M | +2,734 (+1.2%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PCRX insider transactions
latest 13| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Shawn Cross | Sell | $25.16 | 12,941 | $325,596 |
| 2026-04-22 | Shawn Cross | Sell | $25.01 | 1,500 | $37,515 |
| 2026-04-21 | Shawn Cross | Sell | $25.01 | 2,845 | $71,153 |
| 2026-04-20 | Shawn Cross | Sell | $25.14 | 7,714 | $193,930 |
| 2026-03-17 | Jonathan Slonin | Sell | $22.82 | 3,261 | $74,416 |
| 2026-02-02 | Lauren Riker | Sell | $20.81 | 4,000 | $83,240 |
| 2026-01-05 | Lauren Riker | Sell | $24.24 | 1,416 | $34,324 |
| 2025-12-10 | Shawn Cross | Sell | $25.14 | 9,104 | $228,875 |
| 2025-12-09 | Shawn Cross | Sell | $25.03 | 15,896 | $397,877 |
| 2025-11-17 | Jonathan Slonin | Sell | $24.09 | 3,960 | $95,396 |
| 2025-11-17 | Jonathan Slonin | Sell | $24.09 | 3,960 | $95,396 |
| 2025-08-07 | Marcelo Bigal | Sell | $23.67 | 4,912 | $116,267 |
| 2025-06-04 | Lauren Riker | Sell | $26.21 | 5,578 | $146,199 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PCRX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PCRX
Institutional investors own 105.9% of Pacira BioSciences's shares and insiders 1.34%. The largest holder is BlackRock Inc with 16.82% of the shares (6.7M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 9 reduced their stake in the latest filings. Short interest is 29.12% of the float, or 14.52 days of average trading volume. The share count rose 3.4% since 2014.
Related: PCRX analyst forecast, PCRX key metrics. See the PCRX stock overview for the latest quote and news.
PCRX ownership FAQ
Who owns the most Pacira BioSciences stock?
The largest shareholders of Pacira BioSciences are BlackRock Inc (16.82%), Doma Perpetual Capital Management LLC (6.97%), Vanguard Portfolio Management, LLC (6.04%), Dimensional Fund Advisors, Inc. (5.28%), State Street Corp (5.17%).
What percentage of Pacira BioSciences is owned by institutions?
Institutions hold 105.9% of Pacira BioSciences's shares outstanding; insiders hold 1.34%.
Which funds own Pacira BioSciences?
The largest fund holders of Pacira BioSciences are iShares Core S&P Small-Cap ETF (5.95%), Vanguard MStar Total Stk Mkt Idx Invest (3.01%), iShares Russell 2000 ETF (2.57%), Avantis US Small Cap Value ETF (2.25%), Vanguard Small Cap Index (2.03%).
What is Pacira BioSciences's short interest?
8.1M shares of Pacira BioSciences were sold short, 29.12% of the float; at the average daily volume it would take 14.52 days to cover.
Are insiders buying or selling Pacira BioSciences?
Of the latest 13 reported insider transactions in Pacira BioSciences (since June 4, 2025), 0 were purchases and 13 were sales.
How many shares of Pacira BioSciences are outstanding?
Pacira BioSciences has 39.9M shares outstanding, of which 39.1M are in the public float.